EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay

Aleksandra Pettke iD, Marton Keszei, Wanda Christ, Nuria Mayola Danés, Sara Gredmark-Russ, Sandra Söderholm, Finn Filén, Elisabet Storgärd, Victor Westergren, Victor Yman, Johan Aarum, Jonas Klingström und 3 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00182-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Aleksandra Pettke und 14 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Agency of Sweden, Solna, Sweden. Hauptthemen laut MEDLINE: Antibodies, Viral, Vaccinia virus, Antigens, Viral, Monkeypox virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Medical Society, Svenska Sällskapet för Medicinsk Forskning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study’s aim was to evaluate and benchmark the gold-standard methods neutralization test (NT) and immunofluorescence (IF), against a model linked to a multiplex immunoassay method for analysis of the highly cross-reactive serological responses against the monkeypox (MPXV)- and vaccinia (VACV) viruses. Serum samples from men who have sex with men were analyzed (22 with previous PCR-confirmed mpox episode, 53 MVA-BN-vaccinated, 61 unexposed to infection/vaccination). In-house NTs and IF established titers of mpox- and vaccinia-specific neutralizing and binding IgG antibodies, respectively. The commercial Orthopoxvirus Panel 1 multiplex immunoassay (Meso Scale Discovery [MSD]) was used to measure IgG against five homologous MPXV and VACV antigens. Antibody titers were studied in relation to infection and vaccination. The gold-standard NT and IF assays had ≥90% sensitivity identifying mpox-infected individuals. Despite high specificities in the unexposed group (≥91.8%), serum samples of vaccinated individuals strongly cross-reacted in the gold-standard assays with specificities of 73.6% (MPXV NT) and 43.4% (MPXV IF). Similarly, in the MSD assay, no individual antigen could differentiate between MPXV- or VACV-specific IgG antibodies. However, using ratios of IgG concentrations against three MPXV/VACV antigens enabled classification of separated mpox infected, vaccinated, and unexposed individuals with 88.9% accuracy. Through an innovative analytic approach, utilizing antibody response ratios to homologous MPXV and VACV antigen pairs, we demonstrate a model which differentiates MPXV-infected individuals from vaccinated and unexposed. This approach shows promise as a tool for transmission surveillance and outbreak monitoring, particularly in resource poor settings with low diagnostic capacity, and to prioritize vaccine. IMPORTANCE Our study provides a uniquely broad perspective on orthopox serology by contrasting the gold standard NT and IF methods with the novel MSD multiplex assay and by providing an analysis model of multiplex data to separate previously mpox-infected, MVA-BN-vaccinated, and unexposed individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralVaccinia virusAntigens, ViralMonkeypox virusMpox, MonkeypoxHumansMaleImmunoassayImmunoglobulin GSensitivity and SpecificityCross ReactionsAdultAntibodies, NeutralizingNeutralization TestsYoung Adult

Stichwörter der Autor:innen

MPXVVACVdifferentiationimmunizationserology

Substanzen

Antibodies, ViralImmunoglobulin GAntigens, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Public Health Agency of Sweden, Solna, Sweden.
  • Department of Clinical Science and Education, Södersjukhuset Karolinska Institutet, Stockholm, Sweden.
  • Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine Huddinge, Centre for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden.

ORCID-Profile: Aleksandra Pettke, Klara Sondén

Förderung

  • Swedish Medical Society
  • Svenska Sällskapet för Medicinsk Forskning

Zitieren

APA

Pettke, A., Keszei, M., Christ, W., Mayola Danés, N., Gredmark-Russ, S., Söderholm, S., Filén, F., Storgärd, E., Westergren, V., Yman, V., Aarum, J., Klingström, J., Johansen, K., Ekström, A. M., & Sondén, K. (2025). Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00182-25

Vancouver

Pettke A, Keszei M, Christ W, Mayola Danés N, Gredmark-Russ S, Söderholm S, et al. Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00182-25

BibTeX
@article{Pettke2025,
  author = {Pettke, Aleksandra and Keszei, Marton and Christ, Wanda and Mayola Danés, Nuria and Gredmark-Russ, Sara and Söderholm, Sandra and Filén, Finn and Storgärd, Elisabet and Westergren, Victor and Yman, Victor and Aarum, Johan and Klingström, Jonas and Johansen, Kari and Ekström, Anna Mia and Sondén, Klara},
  title = {Serological differentiation between naturally acquired mpox and MVA-BN-vaccine induced antibody responses using ratios of MPXV and VACV antigen pairs in the MSD immunoassay},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00182-25}
}
Kostenlos starten →